表紙
市場調査レポート

遺伝子型決定の世界市場予測 2020年:ポリメラーゼ連鎖反応・シーケンシング・マイクロアレイ・電気泳動法・MALDI_TOF法

Genotyping Market by Technology (Polymerase Chain Reaction, Sequencing, Microarray, Electrophoresis, MALDI_TOF), Application (Pharmacogenomics, Diagnostic Research, Animal Genetics, Agricultural Biotechnology) & by Products - Global Forecast to 2020

発行 MarketsandMarkets 商品コード 330495
出版日 ページ情報 英文 183 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
遺伝子型決定の世界市場予測 2020年:ポリメラーゼ連鎖反応・シーケンシング・マイクロアレイ・電気泳動法・MALDI_TOF法 Genotyping Market by Technology (Polymerase Chain Reaction, Sequencing, Microarray, Electrophoresis, MALDI_TOF), Application (Pharmacogenomics, Diagnostic Research, Animal Genetics, Agricultural Biotechnology) & by Products - Global Forecast to 2020
出版日: 2015年05月15日 ページ情報: 英文 183 Pages
概要

世界の遺伝子型決定市場は、2015年から2020年の間22.3%のCAGRで成長し、2020年に170億米ドルに達すると予測されています。技術進歩、DNAシーケンシングの価格低下、遺伝病発症率の増加、オーダーメイド医療の認識の高まり、創薬における薬理ゲノミクスの需要拡大、および家畜などにおける遺伝分析の利用増加が同市場の成長を促進しています。

当レポートでは、世界の遺伝子型決定市場について調査し、市場概要と産業構造、製品・技術・用途・エンドユーザー・地域別の市場分析、市場成長への各種影響因子と市場機会の分析、競合環境と市場シェア、および主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 遺伝子型決定市場の成長可能性
  • アジア太平洋地域における遺伝子型決定市場
  • 遺伝子型決定市場:地域の成長機会
  • 地域ミックス:遺伝子型決定市場、技術別
  • 遺伝子型決定市場:用途・地域別
  • 遺伝子型決定市場:地域別

第5章 市場概要

  • イントロダクション
  • 市場区分
    • 製品別
    • 技術別
    • 用途別
    • エンドユーザー別
  • 市場ダイナミクス
    • 成長推進因子
    • 成長阻害因子
    • 機会
    • 課題

第6章 産業考察

  • イントロダクション
  • 産業動向
    • 薬理ゲノミクス研究における増加動向
  • ポーターのファイブフォース分析
  • 戦略的ベンチマーキング
    • 企業は市場シェア拡大の主要戦略として新製品発売を採用

第7章 電力サージ保護装置市場:タイプ別

  • イントロダクション
  • 装置
    • シーケンサー & 増幅器
    • アナライザー
  • 試薬 & キット
  • バイオインフォマティクスソフトウェア
  • 遺伝子型決定サービス

第8章 遺伝子型決定市場:技術別

  • イントロダクション
  • マイクロアレイ
  • キャピラリー電気泳動法
    • 制限断片長多型 (RFLP)
    • Amplified Fragment Length Polymorphisms (AFLP)
    • 一本鎖DNA高次構造多型 (SSCP)
  • シーケンシング
    • 次世代シーケンシング (NGS)
    • サンガー氏0件寝具
    • パイロシーケンシング
  • ポリメラーゼ連鎖反応 (PCR)
    • リアルタイムPCR
    • デジタルPCR
  • MALDI-TOF (マトリックス支援レーザー脱離イオン化法-飛行時間質量分析計)
  • その他

第9章 遺伝子型決定市場:用途別

  • イントロダクション
  • 薬理ゲノミクス
  • 診断研究
  • 動物遺伝学
  • 農業バイオテクノロジー
  • その他

第10章 遺伝子型決定市場:エンドユーザー別

  • イントロダクション
  • 医薬品 & バイオ医薬品企業
  • 診断 & 研究ラボ
  • 学術機関

第11章 遺伝子型決定市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • その他 (RoW)

第12章 競合環境

  • 概要
  • 市場シェア分析
  • 主要企業が採用する主な戦略
  • 新製品発売
  • M & A
  • 合意、提携、およびコラボレーション

第13章 企業プロファイル

  • Illumina, Inc
  • Affymetrix, Inc
  • Life Technologies Corporation (Thermofisher Scientific)
  • Agilent Technologies
  • Qiagen NV
  • Sequenom Inc.
  • Fluidigm Corp.
  • Beckman Coulter
  • Roche
  • GE Healthcare

図表リスト

目次
Product Code: BT 3397

Genotyping is used to study genetic variation in the genotypes of living organisms, including humans, animals, plants, and microorganisms. The genotyping market is mainly driven by technological advancements, increasing incidence of genetic diseases and awareness on personalized medicine, decreasing prices of DNA sequencing, growing importance of SNP genotyping in drug development, and the growing demand for genotyping of animal and plant livestock. However, ambiguity in the reimbursement for these products and a lack of well-trained lab technicians are drivers expected to restrain the growth of this market in the forecast period.

The market in this report is broadly segmented based on products and services, technology, applications, and end users. The market, by technology, is segmented into microarrays, capillary electrophoresis, polymerase chain reaction (PCR), sequencing, MALDI-TOF, allele specific oligonucleotide (ASO) probes, and others (in situ hybridization). Sequencing market is forecasted to grow at a highest CAGR 27.7% over the forecast period of 2015-2020, owing to its high speed, accuracy, flexibility, and increasing application areas.

Based on application, the market is segmented into pharmacogenomics, diagnostic research, animal genetics, agricultural biotechnology, and others (prenatal testing, parental testing, forensics, and microbial genotyping). The pharmacogenomics segment is expected to grow at a highest CAGR of 23.4% during the forecast period. The high growth in this segment is attributed to increasing use of genotyping in drug development process & to analyze the effects of drug.

The global genotyping market is expected to grow at a CAGR of 22.3% during the forecast period of 2015 to 2020 to reach $17.0 billion in 2020. Genotyping tests are increasingly being used in drug discovery and development process and to provide personalized therapy, factors that are driving market growth. In addition to this, heavy investments by key manufacturers to offer advanced and innovative products for wider applications are also propelling market growth.

Developed regions like North America and Europe will grow comparatively slower than emerging markets like Asia-Pacific and RoW (Latin America). Emerging countries are expected to record strong growth. Growth will be centered on countries like India, China, and Brazil owing to rising investments by public and private players in these countries, improving healthcare infrastructure, increase in the number of clinical research organizations and clinical trials in these countries, and the focus of leading players to capture growth opportunities in these markets.

Some prominent players in this market include Affymetrix, Inc. (U.S.), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies (U.S.), Beckman Coulter (U.S.), Sequenom, Inc. (U.S.), Roche (Switzerland), GE Healthcare (U.K.), and Fluidigm Corporation (U.S.). Various strategies such as collaborations, expansions, and new product launches helped these companies to maintain their market share and grow in this competitive market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms, and allow them to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report could use one or a combination of the below mentioned strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by top players in the genotyping market. The report analyzes the genotyping market by products and applications.
  • Product Development/Innovation: Detailed insights on upcoming trends, research and development activities, and new product launches in the genotyping market.
  • Market Development: Comprehensive information about lucrative emerging markets by product & services, technology, application, end user, and region.
  • Market Diversification: Exhaustive information about new products, geographies, recent developments, and investments in the genotyping market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products, manufacturing capabilities, and SWOT analyses of leading players in the genotyping market.

Table of Contents

1. Introduction

  • 1.1. Market Scope
    • 1.1.1. Markets Covered
    • 1.1.2. Years Considered for the Study
  • 1.2. Currency & Pricing
  • 1.3. Limitations
  • 1.4. Stakeholders

2. Research Methodology

  • 2.1. Research Data
    • 2.1.1. Secondary Data
      • 2.1.1.1. Key Data From Secondary Sources
    • 2.1.2. Primary Data
      • 2.1.2.1. Key Data From Primary Sources
      • 2.1.2.2. Key Industry Insights
      • 2.1.2.3. Breakdown of Primary Interviews
  • 2.2. Market Size Estimation
  • 2.3. Market Breakdown and Data Triangulation
  • 2.4. Market Share Estimation
  • 2.5. Assumptions for the Study

3. Executive Summary

4. Premium Insights

  • 4.1. Growth Potential of the Genotyping Market
  • 4.2. Genotyping Market in the Asia-Pacific Region
  • 4.3. Genotyping Market: Geographic Growth Opportunities
  • 4.4. Geographic Mix: Genotyping Market, By Technology
  • 4.5. Genotyping Market, By Application & Geography
  • 4.6. Genotyping Market, By Geography

5. Market Overview

  • 5.1. Introduction
  • 5.2. Market Segmentation
    • 5.2.1. Genotyping Market, By Product
    • 5.2.2. Genotyping Market, By Technology
    • 5.2.3. Genotyping Market, By Application
    • 5.2.4. Genotyping Market, By End-User
  • 5.3. Market Dynamics
    • 5.3.1. Market Drivers
      • 5.3.1.1. Advances in Technologies & Decreasing Prices of Dna Sequencing
      • 5.3.1.2. Increasing Incidences and Awareness of Genetic Diseases and Personalized Medicine to Drive the Growth
      • 5.3.1.3. Huge Demand From Emerging Economies With Their Expanding Per Capita Income
      • 5.3.1.4. Growing Importance of Snp Genotyping in the Drug Development Process
      • 5.3.1.5. Increasing Demand for Genome Analysis in Animal and Plant Livestock
    • 5.3.2. Market Restraint
      • 5.3.2.1. Lack of Appropriate Reimbursement Policies
      • 5.3.2.2. Lack of Technical Know-How
    • 5.3.3. Market Opportunity
      • 5.3.3.1. Increasing Access to Healthcare & Growing Investment By Leading Players in Emerging Markets
      • 5.3.3.2. Increasing Demand for Affordable Genotyping Services
      • 5.3.3.3. Increasing Application Areas of Genotyping
    • 5.3.4. Market Challenge
      • 5.3.4.1. Increasing Market Consolidation

6. Industry Insights

  • 6.1. Introduction
  • 6.2. Industry Trends
    • 6.2.1. There is an Increasing Trend in the Pharmacogenomics Study
  • 6.3. Porter's Five Forces Analysis
    • 6.3.1. Threat of New Entrants
    • 6.3.2. Threat of Substitutes
    • 6.3.3. Bargaining Power of Suppliers
    • 6.3.4. Bargaining Power of Buyers
    • 6.3.5. Intensity of Competitive Rivalry
  • 6.4. Strategic Benchmarking
    • 6.4.1. Players Adopted New Product Launches as A Key Strategy to Increase Their Market Shares

7. Genotyping Market, By Product and Services

  • 7.1. Introduction
  • 7.2. Instruments
    • 7.2.1. Sequencers & Amplifiers
    • 7.2.2. Analyzers
  • 7.3. Reagents & Kits
  • 7.4. Bioinformatics Software
  • 7.5. Genotyping Services

8. Genotyping Market, By Technology

  • 8.1. Introduction
  • 8.2. Microarray
  • 8.3. Capillary Electrophoresis
    • 8.3.1. Restriction Fragment Length Polymorphism (RFLP)
    • 8.3.2. Amplified Fragment Length Polymorphisms (AFLP)
    • 8.3.3. Single Strand Conformation Polymorphism (SSCP)
  • 8.4. Sequencing
    • 8.4.1. Next Generation Sequencing (NGS)
    • 8.4.2. Sanger Sequencing
    • 8.4.3. Pyrosequencing
  • 8.5. Polymerase Chain Reaction (PCR)
    • 8.5.1. Real Time PCR
    • 8.5.2. Digital PCR
  • 8.6. Maldi-Tof
  • 8.7. Others

9. Genotyping Market, By Application

  • 9.1. Introduction
  • 9.2. Pharmacogenomics
  • 9.3. Diagnostic Research
  • 9.4. Animal Genetics
  • 9.5. Agricultural Biotechnology
  • 9.6. Others

10. Genotyping Market, By End-User

  • 10.1. Introduction
  • 10.2. Pharmaceutical & Biopharmaceutical Companies
  • 10.3. Diagnostic & Research Laboratories
  • 10.4. Academic Institutions

11. Genotyping Market, By Region

  • 11.1. Introduction
  • 11.2. North America
    • 11.2.1. U.S.
    • 11.2.2. Canada
  • 11.3. Europe
    • 11.3.1. Germany
    • 11.3.2. France
    • 11.3.3. U.K.
    • 11.3.4. Italy
    • 11.3.5. Spain
    • 11.3.6. Rest of Europe (ROE)
  • 11.4. Asia-Pacific
    • 11.4.1. Japan
    • 11.4.2. China
    • 11.4.3. India
    • 11.4.4. Rest of Asia-Pacific
  • 11.5. Rest of the World (RoW)
    • 11.5.1. Latin America
    • 11.5.2. Middle East and Africa

12. Competitive Landscape

  • 12.1. Overview
  • 12.2. Market Share Analysis (2014)
  • 12.3. Key Strategies Adopted By Leading Players
  • 12.4. New Product Launches
  • 12.5. Mergers and Acquisitions
  • 12.6. Agreements, Partnerships, and Collaborations

13. Company Profiles

  • 13.1. Illumina, Inc
    • 13.1.1. Business Overview
    • 13.1.2. Product Portfolio
    • 13.1.3. Key Strategy
    • 13.1.4. Recent Developments
  • 13.2. Affymetrix, Inc
    • 13.2.1. Business Overview
    • 13.2.2. Product Portfolio
    • 13.2.3. Key Strategy
    • 13.2.4. Recent Developments
  • 13.3. Life Technologies Corporation (Thermofisher Scientific)
    • 13.3.1. Business Overview
    • 13.3.2. Product Portfolio
    • 13.3.3. Key Strategy
    • 13.3.4. Recent Developments
  • 13.4. Agilent Technologies
    • 13.4.1. Business Overview
    • 13.4.2. Product Portfolio
    • 13.4.3. Key Strategy
    • 13.4.4. Recent Developments
  • 13.5. Qiagen NV
    • 13.5.1. Business Overview
    • 13.5.2. Product Portfolio
    • 13.5.3. Key Strategy
    • 13.5.4. Recent Developments
  • 13.6. Sequenom Inc.
    • 13.6.1. Business Overview
    • 13.6.2. Product Portfolio
    • 13.6.3. Key Strategy
    • 13.6.4. Recent Developments
  • 13.7. Fluidigm Corp.
    • 13.7.1. Business Overview
    • 13.7.2. Product Portfolio
    • 13.7.3. Key Strategy
    • 13.7.4. Recent Developments
  • 13.8. Beckman Coulter
    • 13.8.1. Business Overview
    • 13.8.2. Product Portfolio
    • 13.8.3. Key Strategy
    • 13.8.4. Recent Developments
  • 13.9. Roche
    • 13.9.1. Business Overview
    • 13.9.2. Product Portfolio
    • 13.9.3. Key Strategy
    • 13.9.4. Recent Developments
  • 13.10. GE Healthcare
    • 13.10.1. Business Overview
    • 13.10.2. Product Portfolio
    • 13.10.3. Key Strategy
    • 13.10.4. Recent Developments

List of Tables

  • Table 1: Global Genotyping Market Size, By Products and Services, 2012-2019 ($Million)
  • Table 2: Global Instruments Market Size for Genotyping, By Country, 2012-2019 ($Million)
  • Table 3: Global Sequencers Market Size for Genotyping, By Country, 2012-2019 ($Million)
  • Table 4: Global Analyzers Market Size for Genotyping, By Country, 2012-2019 ($Million)
  • Table 5: Global Reagents & Kits Market Size for Genotyping, By Country, 2012-2019 ($Million)
  • Table 6: Global Bioinformatics Software Market Size for Genotyping, By Country, 2012-2019 ($Million)
  • Table 7: Global Genotyping Services Market Size, By Country, 2012-2019 ($Million)
  • Table 8: Global Genotyping Market Size, By Technology, 2012-2019 ($Million)
  • Table 9: Global Microarray Market Size for Genotyping, By Country, 2012-2019 ($Million)
  • Table 10: Global Capillary Electrophoresis Market Size for Genotyping, By Type, 2012-2019 ($Million)
  • Table 11: Global Capillary Electrophoresis Market Size for Genotyping, By Country, 2012-2019 ($Million)
  • Table 12: Global RFLP Market Size for Genotyping, By Country, 2012-2019 ($Million)
  • Table 13: Global AFLP Market Size for Genotyping, By Country, 2012-2019 ($Million)
  • Table 14: Global SSCP Market Size for Genotyping, By Country, 2012-2019 ($Million)
  • Table 15: Global Sequencing Market Size for Genotyping, By Country, 2012-2019 ($Million)
  • Table 16: Global Sequencing Market Size for Genotyping, By Type, 2012-2019 ($Million)
  • Table 17: Global NGS Market Size for Genotyping, By Country, 2012-2019 ($Million)
  • Table 18: Global Sanger Sequencing Market Size for Genotyping, By Country, 2012-2019 ($Million)
  • Table 19: Global Pyrosequencing Market Size for Genotyping, By Country, 2012-2019 ($Million)
  • Table 20: Global Polymerase Chain Reaction (PCR) Market Size for Genotyping, By Type, 2012-2019 ($Million)
  • Table 21: Global Polymerase Chain Reaction (PCR) Market Size for Genotyping, By Country, 2012-2019 ($Million)
  • Table 22: Global Real Time PCR Market Size for Genotyping, By Country, 2012-2019 ($Million)
  • Table 23: Global Digital PCR Market Size for Genotyping, By Country, 2012-2019 ($Million)
  • Table 24: Global Maldi-Tof Market Size for Genotyping, By Country, 2012-2019 ($Million)
  • Table 25: Global Other Genotyping Technologies Market Size, By Country, 2012-2019 ($Million)
  • Table 26: Global Genotyping Market Size, By Application, 2012-2019 ($Million)
  • Table 27: Global Genotyping Market Size for Pharmacogenomics, By Country, 2012-2019 ($Million)
  • Table 28: Global Genotyping Market Size for Diagnostic Research, By Country, 2012-2019 ($Million)
  • Table 29: Global Genotyping Market Size for Animal Genetics, By Country, 2012-2019 ($Million)
  • Table 30: Global Genotyping Market Size for Agricultural Biotechnology, By Country, 2012-2019 ($Million)
  • Table 31: Global Genotyping Market Size for Other Applications, By Country, 2012-2019 ($Million)
  • Table 32: Global Genotyping Market Size, By End-User, 2012-2019 ($Million)
  • Table 33: Global Genotyping Market Size for Pharmaceutical & Biopharmaceutical Companies, By Country, 2012-2019 ($Million)
  • Table 34: Global Genotyping Market Size for Diagnostic & Research Laboratories, By Country, 2012-2019 ($Million)
  • Table 35: Global Genotyping Market Size for Academic Institutes, By Country, 2012-2019 ($Million)
  • Table 36: Global Genotyping Market Size, By Region, 2012-2019 ($Million)
  • Table 37: Global Genotyping Market Size, By Country, 2012-2019 ($Million)
  • Table 38: North America: Genotyping Market Size, By Country, 2012-2019 ($Million)
  • Table 39: North America: Market Size, By Product & Services, 2012-2019 ($Million)
  • Table 40: North America: Market Size, By Technology, 2012-2019 ($Million)
  • Table 41: North America: Market Size, By Application, 2012-2019 ($Million)
  • Table 42: North America: Genotyping Market Size, By End-User, 2012-2019 ($Million)
  • Table 43: U.S.: Genotyping Market Size, By Product & Services, 2012-2019 ($Million)
  • Table 44: U.S.: Genotyping Market Size, By Technology, 2012-2019 ($Million)
  • Table 45: U.S.: Genotyping Market Size, By Application, 2012-2019 ($Million)
  • Table 46: U.S.: Genotyping Market Size, End-User, 2012-2019 ($Million)
  • Table 47: Canada: Genotyping Market Size, By Product & Services, 2012-2019 ($Million)
  • Table 48: Canada: Market Size, By Technology, 2012-2019 ($Million)
  • Table 49: Canada: Genotyping Market Size, By Application, 2012-2019 ($Million)
  • Table 50: Canada: Market Size, By End-User, 2012-2019 ($Million)
  • Table 51: Europe: Genotyping Market Size, By Country, 2012-2019 ($Million)
  • Table 52: Europe: Genotyping Market Size, By Product & Services, 2012-2019 ($Million)
  • Table 53: Europe: Market Size, By Technology, 2012-2019 ($Million)
  • Table 54: Europe: Genotyping Market Size, By Application, 2012-2019 ($Million)
  • Table 55: Europe: Genotyping Market Size, By End-User, 2012-2019 ($Million)
  • Table 56: Germany: Genotyping Market Size, By Product & Services, 2012-2019 ($Million)
  • Table 57: Germany: Market Size, By Technology, 2012-2019 ($Million)
  • Table 58: Germany: Genotyping Market Size, By Application, 2012-2019 ($Million)
  • Table 59: Germany: Market Size, By End-User, 2012-2019 ($Million)
  • Table 60: France: Genotyping Market Size, By Product & Services, 2012-2019 ($Million)
  • Table 61: France: Genotyping Market Size, By Technology, 2012-2019 ($Million)
  • Table 62: France: Genotyping Market Size, By Application, 2012-2019 ($Million)
  • Table 63: France: Market Size, By End-User, 2012-2019 ($Million)
  • Table 64: U.K.: Genotyping Market Size, By Product & Services, 2012-2019 ($Million)
  • Table 65: U.K.: Genotyping Market Size, By Technology, 2012-2019 ($Million)
  • Table 66: U.K.: Genotyping Market Size, By Application, 2012-2019 ($Million)
  • Table 67: U.K.: Market Size, By End-User, 2012-2019 ($Million)
  • Table 68: Italy: Genotyping Market Size, By Product & Services, 2012-2019 ($Million)
  • Table 69: Italy: Genotyping Market Size, By Technology, 2012-2019 ($Million)
  • Table 70: Italy: Genotyping Market Size, By Application, 2012-2019 ($Million)
  • Table 71: Italy: Genotyping Market Size, By End-User, 2012-2019 ($Million)
  • Table 72: Spain: Genotyping Market Size, By Product & Services, 2012-2019 ($Million)
  • Table 73: Spain: Genotyping Market Size, By Technology, 2012-2019 ($Million)
  • Table 74: Spain: Market Size, By Application, 2012-2019 ($Million)
  • Table 75: Spain: Genotyping Market Size, By End-User, 2012-2019 ($Million)
  • Table 76: ROE: Genotyping Market Size, By Product & Services, 2012-2019 ($Million)
  • Table 77: ROE: Market Size, By Technology, 2012-2019 ($Million)
  • Table 78: ROE: Genotyping Market Size, By Application, 2012-2019 ($Million)
  • Table 79: ROE: Genotyping Market Size, By End-User, 2012-2019 ($Million)
  • Table 80: Asia-Pacific: Genotyping Market Size, By Country, 2012-2019 ($Million)
  • Table 81: Asia-Pacific: Genotyping Market Size, By Product & Services, 2012-2019 ($Million)
  • Table 82: Asia-Pacific: Market Size, By Technology, 2012-2019 ($Million)
  • Table 83: Asia-Pacific: Genotyping Market Size, By Application, 2012-2019 ($Million)
  • Table 84: Asia-Pacific: Genotyping Market Size, By End-User, 2012-2019 ($Million)
  • Table 85: Japan: Genotyping Market Size, By Product & Services, 2012-2019 ($Million)
  • Table 86: Japan: Genotyping Market Size, By Technology, 2012-2019 ($Million)
  • Table 87: Japan: Market Size, By Application, 2012-2019 ($Million)
  • Table 88: Japan: Genotyping Market Size, By End-User, 2012-2019 ($Million)
  • Table 89: China: Genotyping Market Size, By Product & Services, 2012-2019 ($Million)
  • Table 90: China: Genotyping Market Size, By Technology, 2012-2019 ($Million)
  • Table 91: China: Market Size, By Application, 2012-2019 ($Million)
  • Table 92: China: Genotyping Market Size, By End-User, 2012-2019 ($Million)
  • Table 93: India: Genotyping Market Size, By Product & Services, 2012-2019 ($Million)
  • Table 94: India: Genotyping Market Size, By Technology, 2012-2019 ($Million)
  • Table 95: India: Genotyping Market Size, By Application, 2012-2019 ($Million)
  • Table 96: India: Market Size, By End-User, 2012-2019 ($Million)
  • Table 97: RoAPAC: Genotyping Market Size, By Product & Services, 2012-2019 ($Million)
  • Table 98: RoAPAC: Genotyping Market Size, By Technology, 2012-2019 ($Million)
  • Table 99: RoAPAC: Market Size, By Application, 2012-2019 ($Million)
  • Table 100: RoAPAC: Genotyping Market Size, By End-User, 2012-2019 ($Million)
  • Table 101: RoW: Genotyping Market Size, By Country/Region, 2012-2019 ($Million)
  • Table 102: RoW: Genotyping Market Size, By Product & Services, 2012-2019 ($Million)
  • Table 103: RoW: Market Size, By Technology, 2012-2019 ($Million)
  • Table 104: RoW: Genotyping Market Size, By Application, 2012-2019 ($Million)
  • Table 105: RoW: Genotyping Market Size, By End-User, 2012-2019 ($Million)
  • Table 106: Latin America: Genotyping Market Size, By Product & Services, 2012-2019 ($Million)
  • Table 107: Latin America: Genotyping Market Size, By Technology, 2012-2019 ($Million)
  • Table 108: Latin America: Market Size, By Application, 2012-2019 ($Million)
  • Table 109: Latin America: Genotyping Market Size, By End-User, 2012-2019 ($Million)
  • Table 110: Middle East and Africa: Genotyping Market Size, By Product & Services, 2012-2019 ($Million)
  • Table 111: Middle East and Africa: Genotyping Market Size, By Technology, 2012-2019 ($Million)
  • Table 112: Middle East and Africa: Market Size, By Application, 2012-2019 ($Million)
  • Table 113: Middle East and Africa: Genotyping Market Size, By End-User, 2012-2019 ($Million)

List of Figures

  • Figure 1: Global Genotyping Market
  • Figure 2: Research Methodology
  • Figure 3: Bottom-Up Approach
  • Figure 4: Top-Down Approach
  • Figure 5: Data Triangulation Methodology
  • Figure 6: Global Genotyping Market Size, By Product, 2014 Vs.2019 ($ Million)
  • Figure 7: Global Genotyping Market Size, By Application, 2014 Vs.2019 ($ Million)
  • Figure 8: Geographical Snapshot of the Genotyping Market, 2014
  • Figure 9: High Growth in Asia-Pacific Market Provides Significant Opportunities for the Global Genotyping Market
  • Figure 10: at tractive Growth Opportunities in the Genotyping Market
  • Figure 11: U.S. to Command More Than One-Third of the Global Genotyping Market
  • Figure 12: North America to Account for the Largest Share of the Market During the Forecast Period
  • Figure 13: Genotyping Market, By Product
  • Figure 14: Genotyping Market, By Technology
  • Figure 15: Market, By Application
  • Figure 16: Market, By End-User
  • Figure 17: Drivers, Restraints, Opportunities & Threats for Genotyping Market
  • Figure 18: Increasing Pharmacogenomics Study
  • Figure 19: Porter's Five Forces Analysis: Genotyping Products Manufacturing is A Capital-Intensive Industry
  • Figure 20: Strategic Benchmarking: New Product Launches, A Key Strategy Adopted By Leading Players
  • Figure 21: Reagents & Kits is the Fastest Growing Segment of Genotyping Market
  • Figure 22: Pharmacogenomics is the Fastest Growing Segment of Genotyping Market
  • Figure 23: Pharmaceutical & Biopharmaceutical is the Fastest Growing End-User of Genotyping Market
  • Figure 24: Asia-Pacific to Grow at the Highest CAGR During the Forecast Period
  • Figure 25: Scenario in the Asia-Pacific Soft Tissue Repair Market, 2014
  • Figure 26: New Product Launches is the Key Growth Strategy Adopted By A Majority of the Leading Players
  • Figure 27: Global Soft Tissue Repair Market Share Analysis, By Key Player, 2014
  • Figure 28: Battle for Market Share: New Product Launches Was the Key Strategy
  • Figure 29: Geographic Revenue Mix of Key Players, 2014
  • Figure 30: Illumina, Inc. (Illumina): Company Snapshot
  • Figure 31: Affymetrix Inc.: Company Snapshot
  • Figure 32: Thermo Fisher Scientific Inc.: Company Snapshot
  • Figure 33: Agilent Technologies, Inc.: Company Snapshot
  • Figure 34: Qiagen N.V.: Company Snapshot
  • Figure 35: Fluidigm Corporation: Company Snapshot
  • Figure 36: F. Hoffmann-La Roche Ltd.: Company Snapshot
  • Figure 37: General Electric Company: Company Snapshot
Back to Top